DDInter1250 DDInter875
Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces cerevisiae* and self-assembled into VLPs.
Muromonab {u} may cause a minor interaction that can limit clinical effects when taken with {v} Zinc gluconate
Muromonab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ocrelizumab
Muromonab {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Anakinra
Muromonab {u} may lead to a major life threatening interaction when taken with {v} Natalizumab
Muromonab {u} may lead to a major life threatening interaction when taken with {v} Etanercept
Muromonab may cause a minor interaction that can limit clinical effects when taken with Zinc gluconate
Muromonab may cause a moderate interaction that could exacerbate diseases when taken with Ocrelizumab
Muromonab may cause a moderate interaction that could exacerbate diseases when taken with Anakinra
Muromonab may lead to a major life threatening interaction when taken with Natalizumab
Muromonab may lead to a major life threatening interaction when taken with Etanercept